Slides and pitch decks from 9th December 2014 event at TRI

1. Healthtech Innovation Queensland
9th December 2014 MeetUp at
TRI
Translational Research Institute
Showcasing 5 excellent
Health and Medical Start-ups

2. Thankyou for supporting
Healthtech Innovation Queensland
We are here to:
Build a dynamic healthcare innovation
community in Queensland
Foster, attract, retain and globally
commercialise healthtech start-ups
Make a difference to individual & community
health & wellbeing

3. Entrepreneurs Transforming
Healthcare
Startup Health USA
Check out this excellent video to see
our vision for this group
https://www.youtube.com/watch?feature=player_detailpage&v=oLjtIYEQM_c

4. Healthcare Innovation Investment
Around the World is on the Move
In the USA alone
• $5 billion invested in digital health alone the
1st 3 Qtrs 2014
• Funding to nearly double year-over-year

5. Healthcare Innovation in Australia
• Australia’s health tech start-up scene is active
• Funding & resourcing remains a major issue for start-ups
• No dedicated healthcare incubators and accelerators
• We are planning to start Healthtech weekend workshops
in the New Year with a focus on investment readiness and
growth strategies

6. What Can We Do to Make Queensland a
Healthcare Innovation Hub?
We MUST
• Get researchers, innovators, government,
corporates and investors collaborating,
supporting and investing in the sector
• Build national & international networks and
strategic alliances

7. Welcome to the following
Healthtech Queensland Start-ups
Panel
Dr Carrie Hillyard, Scientist, VC, Deputy Chairman of the Mater Medical
Research Institute , Chairman FizzioFit, Fitgenes and more
Dr Clarence Tan, Asia Pacific Ambassador Singularity University , Angel
Investor, CEO and Chairman, Bond Wireless , Adjunct Professor Bond /Griffith
Universities
Bernie Woodcroft, Director iLab

8. QHeart Medical
Innovative Heart Therapy
Peter W Walsh, Ph.D.
CEO & President
QHeart Medical
peter@qheartmedical.com
www.qheartmedical.com Copyright QHeart Medical 2014

9. The Problem: Heart Failure
• Heart failure (HF): 5.7M Americans, 8M EU, 350K AU.
• Incidence increasing ~10% pa.
• 70% of HF patients are hypertensive.
• 26% are in Class III HF and highly unserved.
• 1.8 million patients US & EU in Class III HF unserved.
(hypertension without severe aortic disease) (~47K AU).
• DRH: 17M Americans, min. 10% unserved.
• A large emerging unserved market.

10. Secondary Heart Pump
is the expansion and contraction of the aorta which reduces
heart load and drives coronary blood flow.
Aorta
Left Coronary Artery
• Aortic stiffness 77% higher in hypertensive HF suffers
(Hundley et al, 2001).

11. The Solution: BioQ CA
passive recoil extra aortic balloon counterpulsation
• Gas filled extra aortic
balloon.
• Gas compresses and expands
in response to systolic and
diastolic aortic load (low
fatigue).
• Subcutaneous inflation port
allows adjustment on routine
visits to cardiologist.

12. BioQ CA Features
• Novel extra-aortic balloon (EAB) counterpulsation device.
• Reduces aortic stiffness and restores 2nd heart pump (increase
aortic expansion and contraction).
• Fully implanted, self-powered, no pump or control system, no
leads, non blood contacting, minimally invasive.
• Proof of concept in animal studies:
– Reduced pulse (27%) & mean pressure (10%), &
significant increase in left coronary artery blood flow
(up 39%).
– Chronic safety study data over 2 months (non-GLP).
• Failure mode safe, cost effective.
• No other product that directly restores aortic biomechanics,
restoring blood pressure to normal levels.

13. Current Activities
• Ethics approved at Indian Hospital for first-in-man pilot
clinical study (for study in Q1 2015).
– funded by an Australian-India Council Grant via
UNSW.
• Prep work for pilot clinical study at Princess Alexandra
Hospital (PAH) Brisbane (Q1-Q2 2015).
– funded by Qld Visiting Medical Officer Trust Grant via
PAH.
• Capital raising prep work and offer Q1 2015.
– Product refinement and clinical trials.
– Exit: trade sale or partnership with large medtech
player.
• Exploring partnership with Chinese group.

14. Venture Summary
• Innovative technology serving multiple unmet market need.
• Attractive proof of concept animal data.
• Issued and pending patent protection.
• High potential for disruptive technology (breakthrough).
• Expected reduction in clinical & medication costs.
• Expected improvement in quality of life.
• Competitive, simple, economical product.
• Experienced team and advisors.
• “one of the most exciting growth markets in medical
devices,” Sean Salmon, VP & GM Medtronic CV.

15. Introducing
Kirsty Richardson
Gravity Fit

16. From Astronauts To Athletes

17. GravityFit Therapeutic Exercise System
Revolutionary new science
based on 30 years research and
innovation by the founder of Core Stability
Addresses musculoskeletal conditions
prevalent in modern life
Focusses on sensory effect of Gravity –
developed during research with European
Space Agency
Incorporates
Exercise Tools
Education and Training
Online measurement, methodology and
exercise progressions

18. Current Status
• Q1 2014 - Products manufactured, courses developed, website built
• Q2 2014 – Soft launch commenced with worldwide interest
• Q2/Q3 2014 – Product sales, courses delivered, advocates in Aust, UK,
Courses
Individual Product
sales (wholesale)
Kit
Product sales
(retail)
Europe, US, Asia
• Viable business established through ‘word of mouth’ marketing
• Numerous opportunities identified to expand – funding needed to
capitalise on growth opportunities specifically through extra resources

19. Business Growth Opportunities
•Online Content Distribution
•Online courses for musculo-skeletal experts/ fitness industry
•Level 2 accreditation courses
•Schools/ Aged Care Programs
• International conferences
•US courses in March

•Speaking/trade slots – COPA, Italy
HEALTH SECTOR
•Pharmacy Wellness program
•Whole Body Vibration
•Corporate Health/Wellness
Help me feel better
FITNESS/WELLNESS
•Golf
•Online Golf Drills - mobile application (Golf Aust)
•NZ Golf, UK Golf & US Golf
•Rotation sports
•Tennis, Baseball, Cricket, Swimming
•Ballet and other performance disciplines
Help me live better
SPORT
Help me perform better

20. The Future
GravityGroup – GravityHealth, GravityFX, GravityFit
International Testing &Training Centres
Second/ Third Gen products (sensors and mobile apps)
Smart Performance Suit (wearable technology)
Further innovations based on new science

21. Challenges
Managing quickly growing global interest
• Growth occurring without infrastructure set up/resources
• Staying focussed on key goals – but still remaining flexible!
• Choosing partners and not committing too early
Having a complete system rather than a simple product offering
• Building a brand rather than launching a product
• Perception – more complicated to adopt system
• Education & training required for system
Broad scope - application across markets
• Remaining focussed on low fruit and not grabbing at everything
• Delaying new innovation/ products with applications in other markets

22. We hear you
Introducing
Chris Jeffry
World leader in
screening and diagnosis
of ear disease.

23. PROBLEM
Ear disease is a big problem
WHO warns health crisis if >4%
QLD communities up to 80%
The Australian health system is
desperate to address this issue better
Current system is cumbersome,
expensive and slow

24. PROBLEM

25. SOLUTION
Direct to user, bypasses complicated system
Autonomous screening without specialists
Enables parallel screening
Eliminates wait times (>1 month  instant)

26. Rural
and
Remote
Automated
Diagnostics
General
Practice
Hospitals
MARKETS
Deadly Ears, Deadly Kids,
Deadly Communities
-> $4.1mil per year
-> 4% of Qld market
Australia
1,300,000 referrals per year
->$26mil per year
Positive hospital balance
$10.27mil-to-15mil
Queensland
260,000 referrals per year
$20 per Audeara test
Gross Income: $5.2mil per year
Positive hospital balance of
$2mil-to-3mil

27. Competitors
 Tympany (Ototronix) industry leader in RnD
focused on automated assessment.
 Standard audiometric providers
 Gordon N.Stowe, Guymark, P.C. Werth and
SLE
 AVANT A2D+ - focused on computer
assisted audiology
 Sound scouts and Windows audiometer –
patient focused screening

28. Chris Jeffery
(MBBS, B. Eng,
GCELead)
Robotics and
small scale
electronics
(Australian
Defence Force)
Callum
Potts
(MBBS, BSc,
GCELead)
Former founding
director of
luxury apparel
start-up
TEAM
Logan
Gardner
(MBBS, B. Eng)
Signal
processing and
software design
(Boeing)

29. Execution
Bench-Top
Prototype
IP Secured
TGA/FDA
Trial
Metro
Hospital
Partnership
National
Partnership
Rural Health
OHS Industry
International
Roll Out
Public
Screening

30. MARKETS
Currently Tested
260,000/year in Qld (1.2mil
Australia)
Current Target
Known Problem, No Access
Rural, remote, ATSI
communities
OH&S on mining/industrial
sites (interest exists)
Access, Needs Screening
Older population
School-based children
No Access, Needs Screening
General population –
hearing ability is not a static
quality

31. Introducing
Horst Thomson
Founder
A Healthy Competition

36. health, productivity, profitability
health, productivity, profitability
Nick Binns
CEO, Co-founder

37. health, productivity, profitability
The impact of unhealthy
workers on the economy
US
$150 billion
productivity
lost
Australia
$17 billion
absenteeism
Source: Gallup Healthways Well-being Index, 2011 37

38. health, productivity, profitability
The problem for CFO
increasing costs
where am I being impacted the most?
what preventive programs work?
how do I know when something changes?
how do I measure the ROI?

39. health, productivity, profitability
Our Solution
Employment
Medical
Health
Management
Injury
Management
Exit Medical
Data
Aggregation
 Hire to retire
 Target quantified
health impacts
 Tailor to meet need
 Proactive & specific
 Quantify ROI

40. health, productivity, profitability
The opportunity
• 600 US Customers
• 65 Australian Customers
• TTM Revenue > $38m
2014
2018
• Proven business model
• 17 Australian Customers
• TTM Growth >100%
• Retention > 95%
Investment
Bootstrap, No Debt
• Scale in US
• Develop predictive capability

41. health, productivity, profitability
Our challenges
• Accelerate revenue growth in Australia
• Land first Customer in US
• Build Team
• Investment to establish & expand in US

42. health, productivity, profitability
health, productivity, profitability
a preventive maintenance platform for the
most important asset
Nick Binns
0409 471151

43. Australia’s First
Fri 13th Feb to Sun 15th Feb 2015

44. • 54 hours to build a startup
• Brings together people with different skillsets to build
innovations and develop .
a commercial case around
them.
• Facilitated and structured, supported by Mentors
• Pitch ideas for new startup companies, form teams
around those ideas, validate them and work to develop
a prototype.
• Pitch presentation by Sunday evening
• 100,000+ participants, in excess 400 cities worldwide

45. • We need mentors.
• 2 hours slot on Sat or Sun
.
• Varied expertise
• We need marketing channel suggestions for
participants
• Email - Bernie.Woodcroft@ilab.com.au

46. Going Forward!
We NEED your input to make this forum work
Please provide some feed back
Any Volunteers!

47. Thankyou to Our Sponsors
A progressive, multidisciplinary firm with a commitment to supporting technology &
fast growth companies with global ambitions, particularly in the health tech space.
R& D Tax Incentives and Export Marketing Development Grants
Bridging loans for R&D tax incentive recipients
Digital media design and production, marketing & communications

48. Very Special Thanks to

49. For more information about
‘Healthtech Innovation Queensland’
Please contact the organizers
Greg Beaver greg.beaver@fitgenes.com 0413585026
Tracey Porst tracey.porst@fitgenes.com 0409302694
John Driscoll john.driscoll@altezzapartners.com.au 0413967398